PhOxi-seq Detects Enzyme-Dependent m 2 G in Multiple RNA Types
ACS Chemical Biology · 2024
DOI: 10.1021/acschembio.4c00548 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Chemical Biology, 2024. Verfasst von Marie Klimontova und 5 weiteren Autor:innen. Beteiligte Einrichtung: The Gurdon Institute and Department of Pathology, University of Cambridge, Cambridge CB2 1QN, United Kingdom. Hauptthemen laut MEDLINE: RNA. Die Arbeit nennt 25 Literaturangaben. Gefördert von: Wellcome Trust, Ontario Ministry of Research and Innovation, Canada Foundation for Innovation.
Abstract (Originalsprache)
In recent years, RNA-modifying enzymes have gained significant attention due to their impact on critical RNA-based processes and, consequently, human pathology. However, identifying sites of modifications throughout the transcriptome remains challenging largely due to the lack of accurate and sensitive detection technologies. Recently, we described PhOxi-seq as a method capable of confirming known sites of m2G within abundant classes of RNA, namely, purified rRNA and purified tRNA. Here, we further explore the selectivity of PhOxi-seq and describe an optimized PhOxi-seq workflow, coupled to a novel bioinformatic pipeline, that is capable of detecting enzyme-dependent m2G sites throughout the transcriptome. In this way, we generated a database of potential THUMPD3-dependent m2G sites in multiple RNA classes within a human cancer cell line and further identify potential non-THUMPD3 controlled m2G sites. These potential sites should serve as the basis for further confirmation studies for m2G within the human transcriptome.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- The Gurdon Institute and Department of Pathology, University of Cambridge, Cambridge CB2 1QN, United Kingdom.
- STORM Therapeutics Ltd., Babraham Research Campus, Cambridge CB22 3AT, United Kingdom.
- Department of Chemistry and Centre for Research on Biomolecular Interactions, York University, Toronto, Ontario M3J 1P3, Canada.
- Milner Therapeutics Institute, University of Cambridge, Cambridge CB2 0AW, United Kingdom.
ORCID-Profile: Ryan Hili
Förderung
- Wellcome Trust
- Ontario Ministry of Research and Innovation
- Canada Foundation for Innovation
- York University
- Natural Sciences and Engineering Research Council of Canada
- Cancer Research UK
- Storm Therapeutics
Zitieren
APA
Klimontova, M., Chung, K. C. K., Zhang, H., Kouzarides, T., Bannister, A. J., & Hili, R. (2024). PhOxi-seq Detects Enzyme-Dependent m 2 G in Multiple RNA Types. ACS Chemical Biology. https://doi.org/10.1021/acschembio.4c00548
Vancouver
Klimontova M, Chung KCK, Zhang H, Kouzarides T, Bannister AJ, Hili R. PhOxi-seq Detects Enzyme-Dependent m 2 G in Multiple RNA Types. ACS Chemical Biology. 2024. doi:10.1021/acschembio.4c00548
BibTeX
@article{Klimontova2024,
author = {Klimontova, Marie and Chung, Kimberley Chung Kim and Zhang, Han and Kouzarides, Tony and Bannister, Andrew J and Hili, Ryan},
title = {PhOxi-seq Detects Enzyme-Dependent m 2 G in Multiple RNA Types},
journal = {ACS Chemical Biology},
year = {2024},
doi = {10.1021/acschembio.4c00548}
}
EUVIMED